Cell-Secreted Vesicles: Novel Opportunities in Cancer Diagnosis, Monitoring and Treatment.
cancer biology
extracellular vesicles
liquid biopsy
therapeutic tools
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
19 Jun 2021
19 Jun 2021
Historique:
received:
18
05
2021
revised:
12
06
2021
accepted:
15
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
Extracellular vesicles (EVs) are important mediators of intercellular communication playing a pivotal role in the regulation of physiological and pathological processes, including cancer. In particular, there is significant evidence suggesting that tumor-derived EVs exert an immunosuppressive activity during cancer progression, as well as stimulate tumor cell migration, angiogenesis, invasion and metastasis. The use of EVs as a liquid biopsy is currently a fast-growing area of research in medicine, with the potential to provide a step-change in the diagnosis and treatment of cancer, allowing the prediction of both therapy response and prognosis. EVs could be useful not only as biomarkers but also as drug delivery systems, and may represent a target for anticancer therapy. In this review, we attempted to summarize the current knowledge about the techniques used for the isolation of EVs and their roles in cancer biology, as liquid biopsy biomarkers and as therapeutic tools and targets.
Identifiants
pubmed: 34205256
pii: diagnostics11061118
doi: 10.3390/diagnostics11061118
pmc: PMC8233857
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Br J Cancer. 2015 Jul 14;113(2):275-81
pubmed: 26057451
Prostate. 2017 May;77(13):1335-1343
pubmed: 28762517
Int J Biochem Cell Biol. 2012 Sep;44(9):1574-84
pubmed: 22728313
Cell. 2012 Dec 21;151(7):1542-56
pubmed: 23260141
Cell Res. 2018 Aug;28(8):862-864
pubmed: 29959401
J Thromb Haemost. 2016 Jan;14(1):48-56
pubmed: 26564379
Gastroenterology. 1996 Jun;110(6):1897-904
pubmed: 8964416
J Extracell Vesicles. 2018 Aug 07;7(1):1505403
pubmed: 30108686
Nat Commun. 2019 Dec 2;10(1):5476
pubmed: 31792209
Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188463
pubmed: 33137405
Cancer Sci. 2015 Oct;106(10):1362-9
pubmed: 26195069
Int J Nanomedicine. 2020 Aug 26;15:6485-6502
pubmed: 32922012
J Extracell Vesicles. 2013 Mar 05;2:
pubmed: 24009895
Nat Rev Mol Cell Biol. 2006 Sep;7(9):631-43
pubmed: 16912714
Thromb Haemost. 2011 Oct;106(4):712-23
pubmed: 21800005
Oncogene. 2017 Mar 30;36(13):1770-1778
pubmed: 27669441
Science. 2010 May 21;328(5981):1031-5
pubmed: 20378772
Tumour Biol. 2016 Sep;37(9):12743-12753
pubmed: 27448307
Curr Med Chem. 2009;16(25):3267-85
pubmed: 19548866
Curr Biol. 2018 Apr 23;28(8):R435-R444
pubmed: 29689228
Anticancer Agents Med Chem. 2009 Sep;9(7):763-77
pubmed: 19538171
J Extracell Vesicles. 2014 Jul 08;3:
pubmed: 25018865
Biochem Soc Trans. 2013 Feb 1;41(1):277-82
pubmed: 23356297
J Transl Med. 2012 Jun 27;10:134
pubmed: 22738135
Circ Res. 2017 May 12;120(10):1632-1648
pubmed: 28495994
Lab Chip. 2020 May 19;20(10):1762-1770
pubmed: 32338266
J Cell Biochem. 2010 Oct 1;111(2):488-96
pubmed: 20533300
Breast Cancer Res Treat. 2013 Jul;140(2):273-84
pubmed: 23881522
Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3794-9
pubmed: 19234131
Nature. 2015 Nov 5;527(7576):100-104
pubmed: 26479035
Cancer Res. 2016 Apr 1;76(7):1770-80
pubmed: 26992424
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4146-51
pubmed: 22315426
Mol Ther. 2017 Jan 4;25(1):181-191
pubmed: 28129113
Trends Cell Biol. 2009 Feb;19(2):43-51
pubmed: 19144520
Sci Rep. 2019 Jan 24;9(1):663
pubmed: 30679544
J Clin Invest. 2010 Feb;120(2):457-71
pubmed: 20093776
Oncotarget. 2017 May 30;8(22):36137-36148
pubmed: 28410224
Mol Cancer. 2021 Jan 27;20(1):22
pubmed: 33504342
Oncogene. 2017 Aug 24;36(34):4929-4942
pubmed: 28436951
Cancer Sci. 2017 Jan;108(1):42-52
pubmed: 27762090
J Control Release. 2016 Feb 28;224:77-85
pubmed: 26773767
Blood. 2004 Nov 15;104(10):3257-66
pubmed: 15284116
Biochim Biophys Acta. 2009 Dec;1793(12):1901-16
pubmed: 19781582
J Extracell Vesicles. 2019 Dec 19;9(1):1703244
pubmed: 32002167
Sci Rep. 2016 Apr 12;6:23978
pubmed: 27068479
Science. 2008 Feb 29;319(5867):1244-7
pubmed: 18309083
Nature. 2007 Feb 1;445(7127):554-8
pubmed: 17268469
Oncogenesis. 2015 Aug 17;4:e163
pubmed: 26280654
Blood Rev. 2007 May;21(3):157-71
pubmed: 17118501
Prog Lipid Res. 2017 Apr;66:30-41
pubmed: 28342835
Oncogene. 2019 Jun;38(26):5227-5238
pubmed: 30890754
J Clin Invest. 2013 Apr;123(4):1542-55
pubmed: 23454749
Oncoimmunology. 2017 Aug 11;6(12):e1362530
pubmed: 29209569
J Pathol Transl Med. 2020 Nov;54(6):453-461
pubmed: 33027851
Theranostics. 2020 Jun 12;10(16):7436-7447
pubmed: 32642004
J Extracell Vesicles. 2014 Sep 08;3:
pubmed: 25279113
Nat Cell Biol. 2012 Jun 03;14(7):677-85
pubmed: 22660413
Sci Rep. 2016 Aug 09;6:30386
pubmed: 27503267
Cancer Res. 2010 Dec 1;70(23):9621-30
pubmed: 21098712
J Extracell Vesicles. 2014 Dec 22;3:26913
pubmed: 25536934
Nat Commun. 2017 Jan 09;8:14041
pubmed: 28067230
Eur J Nutr. 2018 Apr;57(3):929-938
pubmed: 28204880
Cell. 2019 Apr 4;177(2):428-445.e18
pubmed: 30951670
Stem Cell Reports. 2017 Jun 6;8(6):1497-1505
pubmed: 28528698
Cell. 2016 Mar 10;164(6):1226-1232
pubmed: 26967288
PeerJ. 2017 Aug 25;5:e3627
pubmed: 28852584
Biotechnol J. 2017 Jan;12(1):
pubmed: 27976834
Curr Opin Cell Biol. 2014 Aug;29:116-25
pubmed: 24959705
Trends Cell Biol. 2014 Jan;24(1):19-25
pubmed: 24287454
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Nature. 2018 Aug;560(7718):382-386
pubmed: 30089911
J Pers Med. 2021 Jan 28;11(2):
pubmed: 33525618
Cell Death Dis. 2016 Jul 28;7(7):e2312
pubmed: 27468688
Int J Cancer. 2015 Feb 15;136(4):E74-84
pubmed: 25066479
Nat Commun. 2016 Nov 24;7:13588
pubmed: 27882925
Oncotarget. 2015 Jan 20;6(2):715-31
pubmed: 25596732
Front Oncol. 2019 May 03;9:356
pubmed: 31131261
Biochim Biophys Acta Proteins Proteom. 2017 Jun;1865(6):664-673
pubmed: 28341602
Cold Spring Harb Perspect Biol. 2014 May 22;6(10):a016857
pubmed: 24851870
Science. 2020 Feb 7;367(6478):
pubmed: 32029601
J Control Release. 2020 Feb;318:1-15
pubmed: 31830541
J Biol Chem. 2016 Jan 22;291(4):1652-1663
pubmed: 26601950
J Surg Oncol. 2017 Jun;115(8):932-940
pubmed: 28334432
Biomed Environ Sci. 2018 Mar;31(3):171-185
pubmed: 29673440
Nat Rev Cancer. 2017 Feb;17(2):131-140
pubmed: 27909339
Biol Cell. 2007 May;99(5):261-71
pubmed: 17288539
Prostate Cancer Prostatic Dis. 2021 Jun;24(2):524-531
pubmed: 33500577
Eur J Pharmacol. 2009 Aug 15;616(1-3):7-15
pubmed: 19464286
Int J Oncol. 2018 Sep;53(3):1013-1026
pubmed: 30015837
Nanomedicine. 2018 Jan;14(1):195-204
pubmed: 28982587
Methods Mol Biol. 2017;1545:91-116
pubmed: 27943209
Metabolomics. 2019 May 30;15(6):86
pubmed: 31147790
Int J Pharm. 2018 May 5;542(1-2):242-252
pubmed: 29555439
Front Oncol. 2021 Mar 02;10:602763
pubmed: 33738245
J Control Release. 2020 Jan 10;317:273-281
pubmed: 31730913
Oncol Lett. 2016 Jan;11(1):500-504
pubmed: 26870240
Sci Rep. 2015 Oct 13;5:14748
pubmed: 26458510
Int J Cancer. 2017 Aug 1;141(3):614-620
pubmed: 28445609
N Engl J Med. 2005 Feb 24;352(8):786-92
pubmed: 15728811
Pharmaceutics. 2020 Dec 01;12(12):
pubmed: 33271883
Mol Ther. 2010 Sep;18(9):1606-14
pubmed: 20571541
J Control Release. 2015 Dec 28;220(Pt B):727-37
pubmed: 26390807
Int J Mol Sci. 2020 Jul 03;21(13):
pubmed: 32635403
J Pharm Pharm Sci. 2011;14(1):67-77
pubmed: 21501554
Oncotarget. 2016 Dec 27;7(52):87081-87090
pubmed: 27894084
Nanomedicine. 2016 Apr;12(3):655-664
pubmed: 26586551
Cell Mol Life Sci. 2018 Jan;75(2):193-208
pubmed: 28733901
Cell Res. 2015 Apr;25(4):412-28
pubmed: 25732677
Eur J Cancer. 2014 Mar;50(5):1025-34
pubmed: 24462375
J Exp Clin Cancer Res. 2019 Jul 18;38(1):317
pubmed: 31319863
Sci Rep. 2017 Mar 17;7:44541
pubmed: 28303926
Clin Cancer Res. 2019 Jan 1;25(1):266-276
pubmed: 30287549
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77
pubmed: 26858453
Int J Cancer. 2017 Jun 1;140(11):2397-2407
pubmed: 28090647
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):E9066-E9075
pubmed: 29073103
PLoS One. 2014 Apr 04;9(4):e92921
pubmed: 24705249
Theranostics. 2020 Jan 16;10(5):2309-2326
pubmed: 32089744
Immunol Cell Biol. 2010 Nov-Dec;88(8):851-6
pubmed: 20458337
Traffic. 2004 Mar;5(3):181-93
pubmed: 15086793
J Neurosci. 2016 Feb 24;36(8):2425-37
pubmed: 26911690
EMBO J. 2009 Apr 22;28(8):1043-54
pubmed: 19300439
Biochem Biophys Res Commun. 2011 Dec 2;415(4):619-26
pubmed: 22079629
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
Mol Ther. 2017 Jul 5;25(7):1665-1675
pubmed: 28284981
Cell Physiol Biochem. 2017;44(5):1741-1748
pubmed: 29216623
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1322-1330
pubmed: 32543905
ACS Nano. 2014 Jan 28;8(1):483-494
pubmed: 24383518
Cancers (Basel). 2021 Feb 13;13(4):
pubmed: 33668490
J Extracell Vesicles. 2018 May 07;7(1):1470442
pubmed: 29760869
Small GTPases. 2017 Oct 2;8(4):220-232
pubmed: 27494381
Nat Cell Biol. 2015 Feb;17(2):183-94
pubmed: 25621950
Biomaterials. 2014 Feb;35(7):2383-90
pubmed: 24345736
Neoplasia. 2017 Nov;19(11):932-940
pubmed: 28963969
Cells. 2019 Jul 25;8(8):
pubmed: 31349740
Oncol Rep. 2017 Aug;38(2):785-798
pubmed: 28656228
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
BMC Cancer. 2019 Feb 11;19(1):137
pubmed: 30744595
Int J Mol Sci. 2019 Jun 11;20(11):
pubmed: 31212641
Nat Cell Biol. 2019 Jan;21(1):9-17
pubmed: 30602770
J Cell Physiol. 2012 Feb;227(2):658-67
pubmed: 21465472
Nat Cell Biol. 2008 May;10(5):619-24
pubmed: 18425114
Ann Oncol. 2010 Sep;21(9):1851-1857
pubmed: 20147742
Mol Med Rep. 2013 Oct;8(4):1272-8
pubmed: 23969721
Cancer Res. 2016 Oct 15;76(20):5962-5969
pubmed: 27569207
Oncotarget. 2016 Aug 9;7(32):51515-51524
pubmed: 27285987
Expert Opin Drug Saf. 2007 Sep;6(5):609-21
pubmed: 17877447
Mol Cancer. 2019 Mar 30;18(1):58
pubmed: 30925921
Cells. 2020 Aug 25;9(9):
pubmed: 32854228
Mol Aspects Med. 2018 Apr;60:27-37
pubmed: 29155161
Cell Rep. 2013 Dec 12;5(5):1159-68
pubmed: 24290760
Sci Rep. 2016 Feb 04;6:20254
pubmed: 26842680
Nature. 2015 Jul 9;523(7559):177-82
pubmed: 26106858
Am J Reprod Immunol. 2021 Feb;85(2):e13367
pubmed: 33118232
Gene. 2017 Aug 5;623:5-14
pubmed: 28438694
Cell. 2020 Aug 20;182(4):1044-1061.e18
pubmed: 32795414
Viruses. 2014 Mar 19;6(3):1365-78
pubmed: 24651030
Int J Mol Sci. 2019 Sep 21;20(19):
pubmed: 31546622
Biotarget. 2017 May;1:
pubmed: 30957074
J Biol Chem. 2014 Aug 8;289(32):22258-67
pubmed: 24951588
J Exp Med. 1996 Mar 1;183(3):1161-72
pubmed: 8642258
Cell Rep. 2020 Oct 13;33(2):108261
pubmed: 33053347
Nat Nanotechnol. 2021 Jun;16(6):734-742
pubmed: 33686255
Front Immunol. 2018 Apr 30;9:738
pubmed: 29760691
Annu Rev Cell Dev Biol. 2014;30:255-89
pubmed: 25288114
J Control Release. 2014 Oct 28;192:262-70
pubmed: 25084218
Oncogene. 2018 Nov;37(47):6105-6118
pubmed: 29991801
Sci Rep. 2016 Apr 18;6:24316
pubmed: 27087061
Life Sci. 2018 Oct 1;210:65-75
pubmed: 30165035
Int J Mol Sci. 2020 Sep 12;21(18):
pubmed: 32932657
J Extracell Vesicles. 2015 Jul 17;4:27031
pubmed: 26194179
Int J Mol Sci. 2020 Sep 04;21(18):
pubmed: 32899828
Philos Trans R Soc Lond B Biol Sci. 2018 Jan 5;373(1737):
pubmed: 29158311
Biomed Res Int. 2018 Jan 30;2018:8545347
pubmed: 29662902
J Cell Biol. 2006 Jun 19;173(6):949-61
pubmed: 16785323
Cancers (Basel). 2021 Mar 02;13(5):
pubmed: 33801459
J Extracell Vesicles. 2016 Oct 31;5:32945
pubmed: 27802845
Acta Biomater. 2020 Jan 1;101:519-530
pubmed: 31629893
Int J Oncol. 2016 Jan;48(1):305-12
pubmed: 26647805
N Engl J Med. 2018 Sep 06;379(10):958-966
pubmed: 30184457
Anal Methods. 2021 Apr 28;13(16):1930-1938
pubmed: 33913941
Traffic. 2003 Apr;4(4):222-31
pubmed: 12694561
Semin Cancer Biol. 2021 Feb;69:212-225
pubmed: 31421263
Cancer Res. 2016 May 15;76(10):2876-81
pubmed: 27013191
Oncotarget. 2015 Oct 6;6(30):29877-88
pubmed: 26337469
Cell. 2019 Jun 13;177(7):1757-1770.e21
pubmed: 31056282
Semin Cell Dev Biol. 2015 Apr;40:41-51
pubmed: 25721812
PLoS One. 2013 Aug 12;8(8):e67268
pubmed: 23950866
Traffic. 2009 Jul;10(7):925-37
pubmed: 19490536
Sci Rep. 2017 Aug 22;7(1):9151
pubmed: 28831121